NCT06998862View on ClinicalTrials.gov

Colchicine in Chronic Kidney Disease Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

744

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2028

Conditions
Chronic Kidney DiseaseCardiovascular Events
Interventions
DRUG

colchicine treatment in chronic kidney disease patients

colchicine treatment 0.5 mg/day

DRUG

placebo treatment

placebo treatment 1 pill/day

Trial Locations (1)

28028

RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

All Listed Sponsors
lead

Hospital General Universitario Gregorio Marañon

OTHER